Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial.
Saved in:
| Title: | Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial. |
|---|---|
| Authors: | Kendall MA; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: kendall@sdac.harvard.edu., Hughes MD; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Kim S; Frontier Science Foundation, Brookline, MA, USA., Aaron LA; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Naini L; DLH Corporation, Bethesda, MD, USA., Suryavanshi N; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins Clinical Research Site, Pune, Maharashtra, India., Shah NS; Rollins School of Public Health, Emory University, Atlanta, GA, USA., Rouzier V; Les Centres Gheskio (Gheskio-INLR), Port-au-Prince, Haiti., Hafkin J; Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA., Sise T; Pharmaceutical Affairs Branch, Division of AIDS, National Institute of Allergy and Infectious Disease, Rockville, MD, USA., Beck J; Pharmaceutical Affairs Branch, Division of AIDS, National Institute of Allergy and Infectious Disease, Rockville, MD, USA., Heckman BE; Frontier Science Foundation, Amherst, NY, USA., Haberer JE; Center for Global Health, Massachusetts General Hospital, Boston, MA, USA., Harrington M; Treatment Action Group, New York, NY, USA., Scarsi KK; Antiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Hesseling AC; Faculty of Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa., Swindells S; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Churchyard GJ; Aurum Institute (NPC), Parktown, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA., Gupta A; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. |
| Source: | Contemporary clinical trials [Contemp Clin Trials] 2025 Nov; Vol. 158, pp. 108084. Date of Electronic Publication: 2025 Sep 22. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
